{"id":115,"date":"2026-04-24T21:11:43","date_gmt":"2026-04-24T21:11:43","guid":{"rendered":"https:\/\/bkbc.net\/index.php\/2026\/04\/24\/europe-not-us-first-to-authorize-modernas-combo-mrna-flu-covid-vaccine\/"},"modified":"2026-04-24T21:11:43","modified_gmt":"2026-04-24T21:11:43","slug":"europe-not-us-first-to-authorize-modernas-combo-mrna-flu-covid-vaccine","status":"publish","type":"post","link":"https:\/\/bkbc.net\/index.php\/2026\/04\/24\/europe-not-us-first-to-authorize-modernas-combo-mrna-flu-covid-vaccine\/","title":{"rendered":"<div>Europe\u2014not US\u2014first to authorize Moderna&#8217;s combo mRNA flu-COVID vaccine<\/div>"},"content":{"rendered":"<div>\n<p>Moderna&#8217;s mRNA-based combination vaccine against both flu and COVID-19 has gotten the green light in Europe\u2014but it continues to be shelved in the US, where it was developed.<\/p>\n<p>This week, the European Commission authorized Moderna to market the vaccine, mRNA-1083 or mCOMBRIAX, making it the world&#8217;s first authorized combination shot for the two respiratory viruses. The decision follows <a href=\"https:\/\/feeds.issuerdirect.com\/news-release.html?newsid=8245752892462590&amp;symbol=MRNA\">a positive review<\/a> in February from a key European Medicines Agency&#8217;s committee, which paved the way for the approval.<\/p>\n<p>Moderna CEO St\u00e9phane Bancel welcomed the news. &#8220;By combining protection against two significant respiratory viruses in a single dose, our vaccine aims to simplify immunization for adults, particularly those at high risk,&#8221; Bancel said <a href=\"https:\/\/feeds.issuerdirect.com\/news-release.html?newsid=6037570860109793&amp;symbol=MRNA\">in a press release<\/a>. &#8220;mCOMBRIAX offers an important new option for Europeans, while also aiming to strengthen the resilience of healthcare systems across Europe.&#8221;<\/p>\n<p><a href=\"https:\/\/arstechnica.com\/health\/2026\/04\/europe-not-us-first-to-authorize-modernas-combo-mrna-flu-covid-vaccine\/\">Read full article<\/a><\/p>\n<p><a href=\"https:\/\/arstechnica.com\/health\/2026\/04\/europe-not-us-first-to-authorize-modernas-combo-mrna-flu-covid-vaccine\/#comments\">Comments<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<div>Amid RFK Jr.&#8217;s anti-vaccine agenda, Moderna withdrew its FDA application last year.<\/div>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[36,37],"class_list":["post-115","post","type-post","status-publish","format-standard","hentry","category-technology","tag-consumer-tech","tag-culture-news"],"_links":{"self":[{"href":"https:\/\/bkbc.net\/index.php\/wp-json\/wp\/v2\/posts\/115","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bkbc.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bkbc.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bkbc.net\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bkbc.net\/index.php\/wp-json\/wp\/v2\/comments?post=115"}],"version-history":[{"count":0,"href":"https:\/\/bkbc.net\/index.php\/wp-json\/wp\/v2\/posts\/115\/revisions"}],"wp:attachment":[{"href":"https:\/\/bkbc.net\/index.php\/wp-json\/wp\/v2\/media?parent=115"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bkbc.net\/index.php\/wp-json\/wp\/v2\/categories?post=115"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bkbc.net\/index.php\/wp-json\/wp\/v2\/tags?post=115"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}